Sefunda is a in-vitro diagnostics startup focussing on AMR and cost-effectivenes. Increasing antimicrobial drug resistance has become a global health threat. According to the CDC around 50% of the 1.6 million new gonorrhea infections/year in the U.S. are resistant to at least one antibiotic.
- https://sefunda.swiss
- +41 61 311 55 37
- info@sefunda.com
- Melanie Schäpers
